Author: Ken Dropiewski

Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year

FY 2022 Annual Revenue of $1.032 billion, Up 22% Versus Prior Year DANVERS, Mass.–(BUSINESS WIRE)–ABIOMED, Inc. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced financial results for the quarter and fiscal year ended March 31, 2022. Financial summary and operational highlights: Revenue for the […]

Acutus Medical Announces Agreements to Fund Strategic Growth Priorities

CARLSBAD, Calif., April 27, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a commitment letter from Deerfield Management Company (“Deerfield”), to refinance its existing debt with a new […]

BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2022

MARLBOROUGH, Mass., April 27, 2022 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing 10.0 percent on a reported basis, 12.6 percent on an operational1 basis and 9.7 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income […]

EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS

IRVINE, Calif., April 26, 2022 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2022. First Quarter Highlights and Outlook Q1 sales grew 10 percent to $1.34 billion; underlying1 13 percent Q1 TAVR sales grew 11 percent; underlying 14 percent Q1 EPS was $0.59; adjusted1 EPS was $0.60 Full year 2022 financial […]

AMGEN ANNOUNCES RESULTS FROM TWO OPEN LABEL EXTENSION STUDIES OF REPATHA® (EVOLOCUMAB)

Studies Showed Sustained Reduction in LDL-C With no new Safety Findings The Combined Studies Evaluated Safety and Tolerability of Repatha in More Than 6,600 Patients for Over Five Years After Completing the Phase 3 FOURIER Trial Repatha is the Longest Studied PCSK9i THOUSAND OAKS, Calif., April 27, 2022 /PRNewswire/ — Amgen (NASDAQ:AMGN) […]

IMPLICITY Raises $23M to Broaden Use of Its Cardiac Remote Monitoring Platform

Series A funding round will accelerate international expansion and fuel AI-based medical algorithm development. CAMBRIDGE, Mass., April 27, 2022 /PRNewswire/ — IMPLICITY®, a leader in remote patient monitoring and cardiac data management solutions, today announced it has raised $23 million in Series A funding led by new investors: Crédit Mutuel Innovation and Bpifrance. Additional investors […]

ISHLT Launches Foundation to Fund Research in Thoracic Transplantation, Mechanical Circulatory Support, and Pulmonary Hypertension

BOSTON, April 27, 2022 /PRNewswire/ — The International Society for Heart and Lung Transplantation (ISHLT) has established a new sister organization: the ISHLT Foundation. This new entity serves as the charitable arm of ISHLT, and will fund a global portfolio of research grants and fellowship awards to improve patient care for advanced heart […]